Big Gain For NovaBay Pharmaceuticals, Inc.
Fri, Jan 09, 2026 at 07:25 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) shot up at $19.16, a gain of 102.5%. On Fri, Jan 09, 2026, NBY:NYSEMKT hit a New 2-Week High of $19.16. The stock appeared on our News Catalysts scanner on Fri, Dec 19, 2025 at 10:45 AM in the 'INVESTOR UPDATE' category. From Fri, Dec 26, 2025, the stock recorded 77.78% Up Days and 80.00% Green Days
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- F45 Training Holdings Inc. (FXLV:NYSE), 809.09%
- Rich Sparkle Holdings Limited (ANPA:NASDAQ), 258.88%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 102.54%
- Valens Semiconductor Ltd. (VLN:NYSE), 58.97%
- GreenPower Motor Company Inc. (GP:NASDAQ), 51.04%
- Alpha Technology Group Limited (ATGL:NASDAQ), 46.96%
- Offerpad Solutions Inc. (OPAD:NYSE), 44.08%
- VCI Global Limited (VCIG:NASDAQ), 41%
- TryHard Holdings Limited (THH:NASDAQ), 36.31%
- Zentalis Pharmaceuticals, Inc. (ZNTL:NASDAQ), 31.69%